Product Information
OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN is a brand product labeled by Novo Nordisk, priced at $331.9004 per ML under NDC 00169413013. Its NADAC has been published 276 times since Jun 23, 2021.
FDA first approved this application on Dec 5, 2017.
Strength
1.34 mg/mL
Manufacturer
Novo NordiskNDC
00169413013
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
SEMAGLUTIDEApproval Type
New Drug (NDA)
FDA Application
NDA209637FDA Approved
12/5/2017
On Market Since
9/30/2020
Pharmacological Classes
Price Statistics
The NADAC for OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN has been published 276 times since Jun 23, 2021, and over the history we have for it it has risen 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $331.9004 per ML |
|---|---|
| All-time high | $331.9930 (May 13, 2026) |
| All-time low | $273.9923 (Jun 23, 2021) |
| 52-week high | $331.9930 |
| 52-week low | $322.2530 |
| Median price | $311.1281 |
| Average price | $305.8106 |
| Largest weekly change | +4.9% (Jan 11, 2023) |
| Weeks tracked | 276 |
| Tracking since | Jun 23, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the semaglutide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novo Nordisk manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
semaglutide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
GLP-1 Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN?
The current National Average Drug Acquisition Cost (NADAC) for OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN, manufactured by Novo Nordisk, is $331.9004 per ML (NDC 00169413013), effective Sep 30, 2026.
How has the price of OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN changed over time?
Over the history we have for it, the NADAC for OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN has risen 21.1%. It has been tracked across 276 weekly CMS publications since Jun 23, 2021.
What are the highest and lowest recorded NADAC prices for OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN?
Since Jun 23, 2021, the NADAC for OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN has ranged from a low of $273.9923 (Jun 23, 2021) to a high of $331.9930 (May 13, 2026), with a median of $311.1281 per ML.
Are there cheaper alternatives to OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN?
No other NADAC-published product currently shares the active ingredient and strength of OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN?
OZEMPIC 1 MG/DOSE (4 MG/3 ML) PEN (NDC 00169413013) is labeled by Novo Nordisk, and CMS classifies it as a brand product.